As revealed by French–American–British (FAB) subtype analysis, the mRNA expression levels of NEDD8, UBA3, UBE2M and RBX1 were higher in AML-M5 patients than in controls (P<0.05, Figure 1G). This evidence concerns the gene NEDD8 and acute myeloid leukemia.